Journal of Enzyme Inhibition and Medicinal Chemistry · 2019 · 25 citations · 58 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryOrganometallic ChemistryStructure-activity RelationshipsBioinorganic ChemistryCoordination ChemistryEnzyme InhibitionLigand BindingStructure-activity Relationship AnalysisBiological Evaluation ReportCarbonic Anhydrase FunctionCarbonic Anhydrase InhibitorsChemical Synthesis Of AnaloguesMedicinal Chemistry ApplicationsOrganometallic Enzyme Inhibition
and ferrocenyl moieties, which were subsequently reacted with amino-sulfonamides in order to obtain carbonic anhydrase (CA, EC 4.2.1.1) inhibitors possessing organometallic moieties in their molecules. The new derivatives were investigated as inhibitors of four human (h) CA isoforms with pharmaceutical applications, such as the cytosolic hCA I, II and VII and the mitochondrial hCA VA. An interesting inhibitory profile against these isoforms was obtained, with some of these metal complexes acting as subnanomolar or low nanomolar inhibitors. They were also thoroughly characterised from the chemical point of view, making them of interest for further developments in the field of metal complexes of sulfonamides with CA inhibitory action.
58
Joseph R. Casey, Patricio E. Morgan, Daniela Vullo et al. · Journal of Medicinal Chemistry · 2004 · 150 citations · Full text
Vladimír Garaj, Luca Puccetti, G. Fasolis et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 148 citations · Full text
Andrea Scozzafava, Fabrizio Briganti, Giovanna Mincione et al. · Journal of Medicinal Chemistry · 1999 · 135 citations · Full text
Silvia Bua, Lorenzo Di Cesare Mannelli, Daniela Vullo et al. · Journal of Medicinal Chemistry · 2017 · 131 citations · Full text